艾瑞布林
医学
转移性乳腺癌
肿瘤科
乳腺癌
内科学
癌症
作者
Junmei Zhang,Xuezheng Wang,Hongjuan Du,Yan Xue
标识
DOI:10.29271/jcpsp.2024.06.682
摘要
Objective: To evaluate the efficacy and safety of eribulin plus anti-angiogenic medicine in metastatic breast cancer (MBC), and explore the potential biomarkers.Study Design: Observational study.
科研通智能强力驱动
Strongly Powered by AbleSci AI